Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target.

Goyal G, Fan T, Silberstein PT.

Fam Cancer. 2016 Jul;15(3):359-66. doi: 10.1007/s10689-016-9883-7.

2.

Clinical and molecular features of young-onset colorectal cancer.

Ballester V, Rashtak S, Boardman L.

World J Gastroenterol. 2016 Feb 7;22(5):1736-44. doi: 10.3748/wjg.v22.i5.1736. Review.

3.

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Slavin TP, Niell-Swiller M, Solomon I, Nehoray B, Rybak C, Blazer KR, Weitzel JN.

Front Oncol. 2015 Sep 29;5:208. doi: 10.3389/fonc.2015.00208. eCollection 2015. Erratum in: Front Oncol. 2015;5:271.

4.

Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.

Papp J, Kovacs ME, Matrai Z, Orosz E, Kásler M, Børresen-Dale AL, Olah E.

Fam Cancer. 2016 Jan;15(1):85-97. doi: 10.1007/s10689-015-9845-5.

5.

Genetic testing for Lynch syndrome: family communication and motivation.

Leenen CH, Heijer Md, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A.

Fam Cancer. 2016 Jan;15(1):63-73. doi: 10.1007/s10689-015-9842-8.

6.

Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.

Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ, Muessig KR, Peterson SK, Syngal S, Acheson LS, Wiesner GL, Reiss JA, Goddard KA.

Cancer. 2015 Sep 15;121(18):3281-9. doi: 10.1002/cncr.29470. Epub 2015 Jun 2.

PMID:
26036338
7.
8.

The evolution of colorectal cancer genetics-Part 1: from discovery to practice.

Schlussel AT, Gagliano RA Jr, Seto-Donlon S, Eggerding F, Donlon T, Berenberg J, Lynch HT.

J Gastrointest Oncol. 2014 Oct;5(5):326-35. doi: 10.3978/j.issn.2078-6891.2014.069. Review.

9.

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321.

10.

Creation of a network to promote universal screening for Lynch syndrome: the LynchSyndrome Screening Network.

Mange S, Bellcross C, Cragun D, Duquette D, Gorman L, Hampel H, Jasperson K.

J Genet Couns. 2015 Jun;24(3):421-7. doi: 10.1007/s10897-014-9770-z. Epub 2014 Sep 16.

11.

The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.

Cohen SA, Leininger A.

Appl Clin Genet. 2014 Jul 22;7:147-58. doi: 10.2147/TACG.S51483. eCollection 2014. Review.

12.

Lynch syndrome: an updated review.

Sehgal R, Sheahan K, O'Connell PR, Hanly AM, Martin ST, Winter DC.

Genes (Basel). 2014 Jun 27;5(3):497-507. doi: 10.3390/genes5030497.

13.

Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives.

Stewart A Phd.

PLoS Curr. 2013 Sep 16;5. pii: ecurrents.eogt.b59a6e84f27c536e50db4e46aa26309c. doi: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c.

14.

Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review.

Tutlewska K, Lubinski J, Kurzawski G.

Hered Cancer Clin Pract. 2013 Aug 12;11(1):9. doi: 10.1186/1897-4287-11-9.

15.

History, genetics, and strategies for cancer prevention in Lynch syndrome.

Kastrinos F, Stoffel EM.

Clin Gastroenterol Hepatol. 2014 May;12(5):715-27; quiz e41-3. doi: 10.1016/j.cgh.2013.06.031. Epub 2013 Jul 23. Review.

16.

Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.

Heine-Bröring RC, Winkels RM, Botma A, van Duijnhoven FJ, Jung AY, Kleibeuker JH, Nagengast FM, Vasen HF, Kampman E.

PLoS One. 2013 Jun 18;8(6):e66819. doi: 10.1371/journal.pone.0066819. Print 2013.

17.

Endometrial and ovarian cancer in women with Lynch syndrome: update in screening and prevention.

Lu KH, Daniels M.

Fam Cancer. 2013 Jun;12(2):273-7. doi: 10.1007/s10689-013-9664-5. Review.

18.

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.

Martowicz A, Rainer J, Lelong J, Spizzo G, Gastl G, Untergasser G.

Mol Cancer. 2013 Jun 10;12:56. doi: 10.1186/1476-4598-12-56.

19.

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Vasen HF, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, Bernstein I, Bertario L, Burn J, Capella G, Colas C, Engel C, Frayling IM, Genuardi M, Heinimann K, Hes FJ, Hodgson SV, Karagiannis JA, Lalloo F, Lindblom A, Mecklin JP, Møller P, Myrhoj T, Nagengast FM, Parc Y, Ponz de Leon M, Renkonen-Sinisalo L, Sampson JR, Stormorken A, Sijmons RH, Tejpar S, Thomas HJ, Rahner N, Wijnen JT, Järvinen HJ, Möslein G; Mallorca group.

Gut. 2013 Jun;62(6):812-23. doi: 10.1136/gutjnl-2012-304356. Epub 2013 Feb 13.

20.

Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.

Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J, Macrae FA, Parry S, Kalady MF, Baron JA, Ahnen DJ, Marchand LL, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Jenkins MA.

J Natl Cancer Inst. 2013 Feb 20;105(4):274-9. doi: 10.1093/jnci/djs525. Epub 2013 Feb 5.

Items per page

Supplemental Content

Write to the Help Desk